Table 1.
Review | Sample/studies | For risperidone | Against risperidone |
---|---|---|---|
Rattehalli et al9 Risperidone vs placebo for schizophrenia |
n = 1363, 10 RCTs | Greater reduction in PANNS/BPRS scores Less number of risperidone subjects left the trial owing to lack of efficacy |
More EPSE but did not reach statistical significance Prolactin elevation |
Hunter et al11 Risperidone vs typical antipsychotic medication for schizophrenia |
n = 2368, 9 RCTs | Better outcomes in both short and long term trials Reduction in relapse rate Less extrapyramidal side effects |
Weight gain Prolactin elevation and sexual side effects were comparable to haloperidol |
Komossa et al14 Risperidone vs other atypical antipsychotics |
n = 7760, 45 RCTs | Better PANNS score reduction than quetiapine and ziprasidone Better than ziprasidone in leaving study due to inefficacy Equal efficacy compared to aripiprazole and amisulpride |
Olanzapine better on PANNS reduction Olanzapine and clozapine better than risperidone in leaving study due to inefficacy EPSE Prolactin elevation |
Abbreviations: RCT, randomized controlled trial; PANNS, positive and negative syndrome scale; BPRS, brief psychiatric scale; EPSE, extra pyramidal side effects.